Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Plant-based drugs are effective and safe alternatives for managing PCOS symptoms.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

PRP treatment can safely boost hormone levels in some IVF patients with low ovarian reserve.

Menopause affects hair and skin; more research needed for treatment.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Electro-acupuncture may help treat PCOS in rats by changing brain DNA methylation.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Healthcare providers need better education and policies to serve transgender individuals effectively.

The document concludes that more research is needed to fully understand the causes of PCOS.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.